CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression (Q26801436)

Europe PubMed Central

title

CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression (English)

0 references

1 reference

1 reference

María Rosa Bono

1

0 references

Dominique Fernández

2

0 references

Felipe Flores-Santibáñez

3

0 references

Mario Rosemblatt

4

0 references

Daniela Sauma

Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade

5

0 references

language of work or name

English

0 references

publication date

14 November 2015

0 references

published in

FEBS Letters

0 references

volume

589

0 references

issue

22

0 references

page(s)

3454-60

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Extracellular ATP in the immune system: more than just a "danger signal".

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Physiology and pathophysiology of purinergic neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Purinergic signaling in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Extracellular adenosine regulates naive T cell development and peripheral maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Adenosine A2A receptors intrinsically regulate CD8+ T cells in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

CD73: a potent suppressor of antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

CD73 and adenosine generation in the creation of regulatory microenvironments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Adenosine kinase and ribokinase--the RK family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

CD39 and CD73 in immunity and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

The CD39-like gene family: identification of three new human members (CD39L2, CD39L3, and CD39L4), their murine homologues, and a member of the gene family from Drosophila melanogaster

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Identification and characterization of CD39/vascular ATP diphosphohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

ENTPD1/CD39 is a promising therapeutic target in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

CD39/NTPDase-1 activity and expression in normal leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Adenosinergic regulation of the expansion and immunosuppressive activity of CD11b+Gr1+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5'-nucleotidase (CD73)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5'-adenosine monophosphate to adenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

CD73 and Ly-6A/E distinguish in vivo primed but uncommitted mouse CD4 T cells from type 1 or type 2 effector cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

T helper 17 cells promote cytotoxic T cell activation in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Tumor-specific Th17-polarized cells eradicate large established melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Th17 cells are long lived and retain a stem cell-like molecular signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

T helper type 17 cells contribute to anti-tumour immunity and promote the recruitment of T helper type 1 cells to the tumour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Th17 cells have stem cell-like features and promote long-term immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Reducing CD73 expression by IL1β-Programmed Th17 cells improves immunotherapeutic control of tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Isolated CD39 expression on CD4+ T cells denotes both regulatory and memory populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Ecto-nucleoside triphosphate diphosphohydrolase 1 (E-NTPDase1/CD39) regulates neutrophil chemotaxis by hydrolyzing released ATP to adenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Dependence of immunoglobulin class switch recombination in B cells on vesicular release of ATP and CD73 ectonucleotidase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Central role of Sp1-regulated CD39 in hypoxia/ischemia protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

IFN-alpha induced adenosine production on the endothelium: a mechanism mediated by CD73 (ecto-5'-nucleotidase) up-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Wnt and beta-catenin signaling target the expression of ecto-5'-nucleotidase and increase extracellular adenosine generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

CD73-generated adenosine: orchestrating the tumor-stroma interplay to promote cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Extracellular adenosine triphosphate and adenosine in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

A2A adenosine receptor may allow expansion of T cells lacking effector functions in extracellular adenosine-rich microenvironments

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Regulatory T cells exert checks and balances on self tolerance and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Regulatory T cells in transplantation: does extracellular adenosine triphosphate metabolism through CD39 play a crucial role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Adenosine regulates CD8 T-cell priming by inhibition of membrane-proximal T-cell receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

A2A adenosine receptor protects tumors from antitumor T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

The A2B adenosine receptor impairs the maturation and immunogenicity of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Adenosine promotes alternative macrophage activation via A2A and A2B receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Immunity, inflammation and cancer: a leading role for adenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Nucleotide receptors: an emerging family of regulatory molecules in blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

High sensitivity of CD4+CD25+ regulatory T cells to extracellular metabolites nicotinamide adenine dinucleotide and ATP: a role for P2X7 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

The role of glycosyl phosphatidyl inositol (GPI)-anchored cell surface proteins in T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Ecto-enzyme and signaling functions of lymphocyte CD73

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

CD73 engagement promotes lymphocyte binding to endothelial cells via a lymphocyte function-associated antigen-1-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

CD8 T cell quiescence revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Cutting edge: The signals for the generation of T cell memory are qualitatively different depending on TCR ligand strength

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Role of PI3K/Akt signaling in memory CD8 T cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Cyclic AMP inhibits Akt activity by blocking the membrane localization of PDK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Signal integration by Akt regulates CD8 T cell effector and memory differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Adenosine A2B receptor blockade slows growth of bladder and breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

Decreased frequency of CD73+CD8+ T cells of HIV-infected patients correlates with immune activation and T cell exhaustion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

The CD39 molecule defines distinct cytotoxic subsets within alloactivated human CD8-positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

7 January 2021

Generation of anti-inflammatory adenosine byleukocytes is regulated by TGF-β

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

7 January 2021

Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

7 January 2021

cAMP-dependent protein kinase (PKA) inhibits T cell activation by phosphorylating ser-43 of raf-1 in the MAPK/ERK pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

7 January 2021

Human TH17 cells are long-lived effector memory cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.07.027

7 January 2021